Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;5(12):2151-2152.
doi: 10.1002/hep4.1769. Epub 2021 Jul 7.

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?

Hans Dieter Nischalke #  1 , Alexandra Klüners #  1 , Jacob Nattermann  1 , Thomas Berg  2 , Christian P Strassburg  1 , Philipp Lutz  1
Affiliations
Comment

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?

Hans Dieter Nischalke et al. Hepatol Commun. 2021 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Memel ZN, Arvind A, Moninuola O, Philpotts L, Chung RT, Corey KE, et al. Aspirin use is associated with a reduced incidence of hepatocellular carcinoma: a systematic review and meta‐analysis. Hepatol Commun 2021;5:133‐143. - PMC - PubMed
    1. Nischalke HD, Lutz P, Krämer B, Söhne J, Müller T, Rosendahl J, et al. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. J Hepatol 2014;61:1073‐1079. - PubMed
    1. Szelenberger R, Kacprzak M, Bijak M, Saluk‐Bijak J, Zielinska M. Blood platelet surface receptor genetic variation and risk of thrombotic episodes. Clin Chim Acta 2019;496:84‐92. - PubMed
    1. Strisciuglio T, Franco D, Di Gioia G, De Biase C, Morisco C, Trimarco B, et al. Impact of genetic polymorphisms on platelet function and response to anti platelet drugs. Cardiovasc Diagn Ther 2018;8:610‐620. - PMC - PubMed
    1. Takami Y, Eguchi S, Tateishi M, Ryu T, Mikagi K, Wada Y, et al. A randomised controlled trial of meloxicam, a Cox‐2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment. Hepatol Int 2016;10:799‐806. - PMC - PubMed

MeSH terms